MedPage Today on MSN
PD-1 Inhibitor Raises PFS in Advanced Acral Melanoma
First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but ...
A systematic review found improved sleep quality and longer REM sleep after endoscopic surgery for chronic rhinosinusitis ...
Patients with primary biliary cholangitis and moderate-to-severe pruritus who received seladelpar over 6 months experienced a ...
Meta analysis in obese colorectal cancer patients found robotic assisted surgery modestly reduced hospital stay versus ...
OhmBody is the first consumer wearable designed to simultaneously engage two cranial nerve pathways — the vagus and trigeminal nerves — reflecting growing scientific understanding that menstruation is ...
The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.
A systematic review and meta-analysis finds that weight-loss interventions are associated with decreased psoriasis severity ...
“Our findings indicate that the vaccine provided a significant enhanced level of protection against these infections in the ...
When a biotech company announces positive Phase 3 trial results or receives FDA approval, the market reaction is often immediate and substantial. This is not just speculation. These milestones ...
Collaborative care, an evidence-based model to treat behavioral health conditions in primary care, did not improve outcomes ...
Tea and coffee are two of the most popular drinks in the world – daily rituals linked to culture, comfort, and productivity.
Christmas traditions such as decorating a tree and singing not only lift spirits but also boost immunity by triggering immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results